Apyx Medical Corp APYX

About Apyx Medical Corp (APYX): stock profile, AI score and financials

Apyx Medical Corp (APYX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores APYX at 27.0/100 on a composite quality score built from its SEC filings, placing it at rank #2,570 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (6.2) and revenue scale (10.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 28.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Apyx Medical Corp reports quarterly revenue of $13.9M, net income of $-3.2M, an operating margin of -13.0%. APYX trades on the Nasdaq exchange and files with the SEC under CIK 719135. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate APYX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Apyx Medical Corp directly from SEC EDGAR.

SEC EDGAR: CIK 719135 →